Clinical Trial Update: Tailored Antiplatelet Therapy During Percutaneous Coronary Intervention in Patients With Diabetes Mellitus [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on tailored antiplatelet therapy during percutaneous coronary intervention in patients with diabetes mellitus; the study status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Snippet

Sponsor: Seoul National University Bundang Hospital | Conditions: Diabetes Mellitus | Phase 4 | Status: COMPLETED